Tandem Diabetes Care (Nasdaq:TNDM) announced today that its users have delivered more than 1 million insulin boluses using its app.
Users of the t:connect app feature on their mobile devices have reached the 1 million insulin bolus milestone with the t:slim X2 insulin pump within the first month following its commercial release.
San Diego-based Tandem designed the t:connect mobile app to offer users of the t:slim X2 insulin pump the ability to program and cancel bolus insulin requests through the convenience of their compatible smartphone. The company said in a news release that it is the first-ever FDA-cleared smartphone application capable of initiating insulin delivery on both iOS and Android operating systems. The company added that it is now available on approximately 30 different devices.
“The rapid adoption of our mobile bolus feature demonstrates the importance of our offering new technologies that provide lifestyle benefits, in addition to improved clinical outcomes, to people living with diabetes,” said John Sheridan, president and CEO of Tandem Diabetes Care. “We are committed to leading in diabetes technology by continually enhancing the solutions we provide and offering best-in-class customer care.”
Offering a smooth transition
According to Tandem, current t:slim X2 pump users in the U.S. can add the app feature at no additional cost and without purchasing any new devices.
Bolus delivery from the t:connect mobile app requires a compatible smartphone and operating system, an app update, a remote software update on the customer’s t:slim X2 pump and additional training.
“The ability to bolus from my phone has been a game changer,” said Lauren Salko, professional freestyle skier and ambassador for Tandem Diabetes Care. “The feature allows me to be more discreet and wear my pump in places I haven’t been able to before. With the freedom to bolus more easily, I feel more on top of my diabetes management.”